Learn / JBIO
NASDAQ: JBIO
Jade Biosciences (JBIO) stock, explained like you're 5
Jade Biosciences trades on the Nasdaq under the ticker JBIO. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 915 million dollars.
- Ticker
- JBIO
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Small cap, about 915 million dollars
Is Jade Biosciences a small, medium or large cap company?
No. Jade Biosciences is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 915 million dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Jade Biosciences makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves JBIO stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Is Jade Biosciences, Inc. (JBIO) Stock a Rising Biotech Opportunity in the $20B IgA Nephropathy Market? (Yahoo Finance)
- JBIO Forecast Price Target Prediction for 2027 (TradingView)
- Watkins Advises Jade Biosciences on Public Offering of Common Stock (Latham & Watkins LLP)
- Jade Biosciences: Duration Is The Real Product (NASDAQ:JBIO) (Seeking Alpha)
- H.C. Wainwright reiterates Jade Biosciences stock rating at buy (Investing.com)
Follow JBIO in your daily brief
Each trading day at 5 PM ET we post what happened to Jade Biosciences and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow JBIO
Questions about Jade Biosciences stock
What does Jade Biosciences do?
Jade Biosciences trades on the Nasdaq under the ticker JBIO. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 915 million dollars.
What is the ticker symbol for Jade Biosciences?
Jade Biosciences trades under the ticker JBIO on the Nasdaq.
What is Jade Biosciences's market cap?
Jade Biosciences is a small cap stock with a market cap of about 915 million dollars.
How does Jade Biosciences make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves JBIO stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow JBIO stock every day?
Add JBIO to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.